Dr. Kempers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
119 14th Street NW, Suite 250
New Brighton, MN 55112Phone+1 763-571-4200Fax+1 763-571-7202
Education & Training
- University of MinnesotaResidency, Dermatology, 1986 - 1989
- Santa Barbara Cottage HospitalInternship, Internal Medicine, 1985 - 1986
- Perelman School of Medicine at the University of PennsylvaniaClass of 1985
Certifications & Licensure
- CA State Medical License 1986 - 2026
- MN State Medical License 1986 - 2025
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis Start of enrollment: 2007 May 07
- Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris Start of enrollment: 2007 Feb 01
- Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLong-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.Linda Stein Gold, David N Adam, Lorne Albrecht, Javier Alonso-Llamazares, Laura K Ferris
Journal of the American Academy of Dermatology. 2024-08-01 - 5 citationsOnce-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.Leon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, Michael Bukhalo, Alim R Devani
The British Journal of Dermatology. 2023-09-15 - 57 citationsSafety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trialKim A. Papp, Reni Bressinck, Scott Fretzin, Bernard S. Goffe, Steven Kempers
International Journal of Dermatology. 2006-05-01
Journal Articles
- Phase 3 Trials of Tirbanibulin Ointment for Actinic KeratosisAndrew Blauvelt, Steven Kempers, Stephen Tyring, Glynis Ablon, The New England Journal of Medicine
- Trial of Roflumilast Cream for Chronic Plaque PsoriasisLeon H Kircik, Steven E Kempers, Howard Welgus, The New England Journal of Medicine
Authored Content
- Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: